rs147258456
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_144991.3(TSPEAR):c.1746C>T(p.Leu582=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00234 in 1,613,766 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0024 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 12 hom. )
Consequence
TSPEAR
NM_144991.3 synonymous
NM_144991.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.05
Genes affected
TSPEAR (HGNC:1268): (thrombospondin type laminin G domain and EAR repeats) This gene encodes a protein that contains a N-terminal thrombospondin-type laminin G domain and several tandem arranged epilepsy-associated repeats (EARs). A mutation in this gene is the cause of autosomal recessive deafness-98. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 21-44509207-G-A is Benign according to our data. Variant chr21-44509207-G-A is described in ClinVar as [Benign]. Clinvar id is 504823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-44509207-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.05 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPEAR | NM_144991.3 | c.1746C>T | p.Leu582= | synonymous_variant | 10/12 | ENST00000323084.9 | NP_659428.2 | |
TSPEAR-AS1 | NR_103707.1 | n.1215-45G>A | intron_variant, non_coding_transcript_variant | |||||
TSPEAR | NM_001272037.2 | c.1542C>T | p.Leu514= | synonymous_variant | 11/13 | NP_001258966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.1746C>T | p.Leu582= | synonymous_variant | 10/12 | 1 | NM_144991.3 | ENSP00000321987 | P1 | |
TSPEAR | ENST00000397916.1 | n.1701C>T | non_coding_transcript_exon_variant | 10/11 | 1 | |||||
TSPEAR-AS1 | ENST00000451035.2 | n.770-45G>A | intron_variant, non_coding_transcript_variant | 5 | ||||||
TSPEAR | ENST00000642437.1 | c.*1691C>T | 3_prime_UTR_variant, NMD_transcript_variant | 11/13 | ENSP00000496535 |
Frequencies
GnomAD3 genomes AF: 0.00237 AC: 361AN: 152164Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
361
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00325 AC: 816AN: 250994Hom.: 4 AF XY: 0.00314 AC XY: 426AN XY: 135724
GnomAD3 exomes
AF:
AC:
816
AN:
250994
Hom.:
AF XY:
AC XY:
426
AN XY:
135724
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00234 AC: 3420AN: 1461484Hom.: 12 Cov.: 32 AF XY: 0.00224 AC XY: 1629AN XY: 727002
GnomAD4 exome
AF:
AC:
3420
AN:
1461484
Hom.:
Cov.:
32
AF XY:
AC XY:
1629
AN XY:
727002
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00237 AC: 361AN: 152282Hom.: 4 Cov.: 32 AF XY: 0.00295 AC XY: 220AN XY: 74462
GnomAD4 genome
AF:
AC:
361
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
220
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 30, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Leu582Leu in exon 10 of TSPEAR: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.3% (26/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs147258456). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at